Impact of preoperative drug therapy on the expression of apoptosis markers in colorectal liver metastases

作者: A. V. Varlamov , E. M. Paltseva , M. I. Sekacheva , D. N. Fedorov , O. G. Skipenko

DOI: 10.17116/PATOL201678125-31

关键词:

摘要: AIM to study changes in the expression of angio- and vasculogenesis markers colorectal adenocarcinoma metastases liver during combined cytotoxic targeted anti-VEGF therapy versus monotherapy. SUBJECTS AND METHODS Intraoperative samples from 96 patients with adenocarcinomas were immunohistochemically examined. The investigation enrolled who had preoperatively received either FOLFOX6 bevacizumab or only therapy, as well not preoperative anti-tumor drug treatment. SDF1α, CXCR4, CXCR7, VEGF-A was compared these groups. Statistical significance accepted at p<0.05. RESULTS CXCR4 vessel endothelial cells significantly less frequently detected those therapy. Comparing treated drugs revealed similar results women. CXCR7 tumor stromal metastatic foci more common group male according regimen. SDF1α often observed than VEGF seen CONCLUSION Combined for leads some suppression alternative pathway formation new vessels, by reducing that foci. In men, this simultaneously causes an increase stroma. Preoperative increases patients, which may suggest can be activated.

参考文章(34)
Christopher G Willett, Yves Boucher, Emmanuelle di Tomaso, Dan G Duda, Lance L Munn, Ricky T Tong, Daniel C Chung, Dushyant V Sahani, Sanjeeva P Kalva, Sergey V Kozin, Mari Mino, Kenneth S Cohen, David T Scadden, Alan C Hartford, Alan J Fischman, Jeffrey W Clark, David P Ryan, Andrew X Zhu, Lawrence S Blaszkowsky, Helen X Chen, Paul C Shellito, Gregory Y Lauwers, Rakesh K Jain, Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nature Medicine. ,vol. 10, pp. 145- 147 ,(2004) , 10.1038/NM988
Seon Ae Roh, Eun Young Choi, Dong Hyung Cho, Yong Sik Yoon, Tae Won Kim, Yong Sung Kim, Jin Cheon Kim, Characterization of biological responses of colorectal cancer cells to anticancer regimens Journal of The Korean Surgical Society. ,vol. 83, pp. 21- 29 ,(2012) , 10.4174/JKSS.2012.83.1.21
Suparna Bonthala Wedam, Jennifer A. Low, Sherry X. Yang, Catherine K. Chow, Peter Choyke, David Danforth, Stephen M. Hewitt, Arlene Berman, Seth M. Steinberg, David J. Liewehr, Jonathan Plehn, Arpi Doshi, Dave Thomasson, Nicole McCarthy, Hartmut Koeppen, Mark Sherman, JoAnne Zujewski, Kevin Camphausen, Helen Chen, Sandra M. Swain, Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer Journal of Clinical Oncology. ,vol. 24, pp. 769- 777 ,(2006) , 10.1200/JCO.2005.03.4645
Joseph Baar, Paula Silverman, Janice Lyons, Pingfu Fu, Fadi Abdul-Karim, Nicholas Ziats, Jay Wasman, Paul Hartman, John Jesberger, Leda Dumadag, Erin Hohler, Rosemary Leeming, Robert Shenk, Helen Chen, Keith McCrae, Afshin Dowlati, Scot C. Remick, Beth Overmoyer, A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers Clinical Cancer Research. ,vol. 15, pp. 3583- 3590 ,(2009) , 10.1158/1078-0432.CCR-08-2917
Benoît Romain, Muriel Hachet-Haas, Serge Rohr, Cécile Brigand, Jean-Luc Galzi, Marie-Pierre Gaub, Erwan Pencreach, Dominique Guenot, Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer Molecular Cancer. ,vol. 13, pp. 58- 58 ,(2014) , 10.1186/1476-4598-13-58
Christian Stockmann, Andrew Doedens, Alexander Weidemann, Na Zhang, Norihiko Takeda, Joshua I. Greenberg, David A. Cheresh, Randall S. Johnson, Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis Nature. ,vol. 456, pp. 814- 818 ,(2008) , 10.1038/NATURE07445
Ryo Matsusue, Hajime Kubo, Shigeo Hisamori, Kae Okoshi, Hidekazu Takagi, Koya Hida, Keiko Nakano, Atsushi Itami, Kenji Kawada, Satoshi Nagayama, Yoshiharu Sakai, Hepatic Stellate Cells Promote Liver Metastasis of Colon Cancer Cells by the Action of SDF-1/CXCR4 Axis Annals of Surgical Oncology. ,vol. 16, pp. 2645- 2653 ,(2009) , 10.1245/S10434-009-0599-X
Christopher G. Willett, Dan G. Duda, Emmanuelle di Tomaso, Yves Boucher, Marek Ancukiewicz, Dushyant V. Sahani, Johanna Lahdenranta, Daniel C. Chung, Alan J. Fischman, Gregory Y. Lauwers, Paul Shellito, Brian G. Czito, Terence Z. Wong, Erik Paulson, Martin Poleski, Zeljko Vujaskovic, Rex Bentley, Helen X. Chen, Jeffrey W. Clark, Rakesh K. Jain, Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study Journal of Clinical Oncology. ,vol. 27, pp. 3020- 3026 ,(2009) , 10.1200/JCO.2008.21.1771
Karin Tamas, Urszula Domanska, Tonnis Dijk, Hetty Timmer-Bosscha, Klaas Havenga, Arend Karrenbeld, Wim Sluiter, Jannet Beukema, Marcel Vugt, Elisabeth Vries, Geke Hospers, Annemiek Walenkamp, CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment. Current Pharmaceutical Design. ,vol. 21, pp. 2276- 2283 ,(2015) , 10.2174/1381612821666150105155615